From robotaxi rollouts to an oral obesity pill and a global push for electrification, three big headlines hint at a near-future shift in everyday life. This page answers the most common questions readers have today and points to what comes next in transport, health, and energy policy.
Robotaxi pilots are accelerating in major cities, with some operators planning London rollouts using safety supervisors and other programs expanding driverless coverage in U.S. metros. In parallel, several firms pause or adjust deployments to fix software and weather-related edge cases. Regulators are evaluating safety plans, including how autonomous systems handle floods and other hazards, before broad consumer fares are approved. Expect announcements on timelines, safety standards, and required mitigations to evolve over the coming months.
The MHRA has approved Wegovy as an oral medication for adults who are obese or overweight with related conditions, making the UK the first European market to authorize an oral GLP-1 weight‑loss treatment. NHS funding will follow NICE appraisal, while private prescriptions become available ahead of public funding. Patients may gain quicker, at-home access to weight‑loss therapy as the NHS workstreams assess cost-effectiveness and long-term outcomes.
Leaders view electrification as central to reducing fossil fuel dependence, with targets to electrify transport, heating, and industry. COP31 discussions focus on stronger grids, faster deployment of renewables, and managing market volatility. The aim is to cut emissions while improving energy security, even as fossil fuel costs influence policy choices and investment in clean energy infrastructure accelerates.
With companies testing in complex urban terrains, safety remains the top constraint. Reduced weather-related incidents and improved routing are guiding pilots, while regulators demand transparent safety and operational plans. Early deployments often combine human oversight with automated systems, offering a bridge to fully autonomous services as confidence and reliability grow.
Expect phased rollouts in major cities, with safety pilots and transparent reporting on incidents and fixes. For health, oral obesity therapies may become more accessible through private channels before NHS funding, depending on NICE decisions. In energy, households should watch for continued investment in grid upgrades, incentives for electric transport, and price signals tied to fossil fuel volatility.
Policy makers aim to accelerate the transition to low-carbon solutions, balancing reliability and affordability. Grid modernization and energy storage advancements are crucial, as are clear timelines for electrification across sectors. In practice, households may see more electric options in transport and home heating, along with potential changes to energy bills tied to broader decarbonization efforts.
Passengers expected to start using autonomous cabs in English capital within two months
Britain's medicines regulator approved Novo Nordisk's weight-loss pill on Thursday, giving patients a new needle-free obesity treatment option and bolstering the Danish drugmaker's first-to-market lead against U.S. rival Eli Lilly .
Faster switch from fossil fuels to electricity will be a “defining” priority of the Antalya conference.